BC

Boxer Capital Portfolio holdings

AUM $2.04B
This Quarter Return
-6.33%
1 Year Return
+108.35%
3 Year Return
+260.95%
5 Year Return
+1,103.68%
10 Year Return
–
AUM
$2.83B
AUM Growth
+$2.83B
Cap. Flow
+$168M
Cap. Flow %
5.92%
Top 10 Hldgs %
45.99%
Holding
98
New
13
Increased
2
Reduced
1
Closed
3

Top Buys

1
BMEA icon
Biomea Fusion
BMEA
$32.6M
2
DAWN icon
Day One Biopharmaceuticals
DAWN
$27.1M
3
GHRS icon
GH Research
GHRS
$22M
4
CNTA
Centessa Pharmaceuticals
CNTA
$20.1M
5
RAIN
Rain Oncology Inc. Common Stock
RAIN
$18.3M

Top Sells

1
LABD icon
Direxion Daily S&P Biotech Bear 3X Shares
LABD
$27.2M
2
ARYD
ARYA Sciences Acquisition Corp IV Class A Odinary Shares
ARYD
$10.3M
3
VINCU
Vincerx Pharma, Inc. Unit
VINCU
$8.1M
4
ACHL
Achilles Therapeutics plc American Depositary Shares
ACHL
$1.88K

Sector Composition

1 Healthcare 97.6%
2 Financials 0.79%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
MRTX
1
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$323M 11.4% 2,000,000 – –
ONC
2
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
$262M 9.25% 764,188 – –
SWTX
3
DELISTED
SpringWorks Therapeutics
SWTX
$171M 6.04% 2,075,905 – –
ITOS icon
4
iTeos Therapeutics
ITOS
$111M 3.93% 4,345,016 – –
RVMD icon
5
Revolution Medicines
RVMD
$7.1B
$111M 3.9% 3,484,264 – –
PMVP icon
6
PMV Pharmaceuticals
PMVP
$74.2M
$77.5M 2.73% 2,268,236 – –
RCKT icon
7
Rocket Pharmaceuticals
RCKT
$354M
$64.9M 2.29% 1,466,051 – –
SGEN
8
DELISTED
Seagen Inc. Common Stock
SGEN
$63.2M 2.23% 400,000 – –
SAGE
9
DELISTED
Sage Therapeutics
SAGE
$62.2M 2.19% 1,094,000 – –
RCUS icon
10
Arcus Biosciences
RCUS
$1.13B
$57.3M 2.02% 2,084,883 – –
SPRY icon
11
ARS Pharmaceuticals
SPRY
$1.15B
$51.8M 1.83% 1,675,377 – –
ARGX icon
12
argenx
ARGX
$43.6B
$51.5M 1.82% 170,926 – –
RLAY icon
13
Relay Therapeutics
RLAY
$619M
$47.4M 1.67% 1,294,132 – –
IDYA icon
14
IDEAYA Biosciences
IDYA
$2.15B
$46.2M 1.63% 2,202,812 – –
MRNS
15
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$43.1M 1.52% 2,400,000 – –
CYTK icon
16
Cytokinetics
CYTK
$4.23B
$41.6M 1.47% 2,100,000 – –
DBVT
17
DBV Technologies
DBVT
$264M
$41.2M 1.45% 7,534,598 – –
CNTB
18
Connect Biopharma
CNTB
$115M
$40.6M 1.43% 2,081,323 – –
NUVB icon
19
Nuvation Bio
NUVB
$1.02B
$40.4M 1.43% 4,341,009 – –
MRUS icon
20
Merus
MRUS
$4.98B
$40M 1.41% 1,900,000 – –
SNDX icon
21
Syndax Pharmaceuticals
SNDX
$1.41B
$39.3M 1.39% 2,287,782 – –
ANAB icon
22
AnaptysBio
ANAB
$569M
$33.7M 1.19% 1,300,000 – –
BMEA icon
23
Biomea Fusion
BMEA
$116M
$32.6M 1.15% +2,088,405 New +$32.6M
NRIX icon
24
Nurix Therapeutics
NRIX
$714M
$32.5M 1.15% 1,224,892 – –
ALGS icon
25
Aligos Therapeutics
ALGS
$73.3M
$31.1M 1.1% 1,526,048 – –
1
2 3 4